Literature DB >> 24406398

Tyrosine phosphorylation of 3BP2 is indispensable for the interaction with VAV3 in chicken DT40 cells.

Kazuyasu Chihara1, Yukihiro Kimura2, Chisato Honjoh3, Shota Yamauchi1, Kenji Takeuchi1, Kiyonao Sada4.   

Abstract

Adaptor protein c-Abl SH3 domain-binding protein-2 (3BP2) is known to play regulatory roles in immunoreceptor-mediated signal transduction. We have previously demonstrated that Tyr(174), Tyr(183) and Tyr(446) in mouse 3BP2 are predominantly phosphorylated by Syk, and the phosphorylation of Tyr(183) and the Src homology 2 (SH2) domain of mouse 3BP2 are critical for B cell receptor (BCR)-induced activation of nuclear factor of activated T cells (NFAT) in human B cells. In this report, we have shown that Syk, but not Abl family protein-tyrosine kinases, is critical for BCR-mediated tyrosine phosphorylation of 3BP2 in chicken DT40 cells. Mutational analysis showed that Tyr(174), Tyr(183) and Tyr(426) of chicken 3BP2 are the major phosphorylation sites by Syk and the SH2 domain of 3BP2 is critical for tyrosine phosphorylation. In addition, phosphorylation of Tyr(426) is required for the inducible interaction with the SH2 domain of Vav3. Moreover, the expression of the mutant form of 3BP2 in which Tyr(426) was substituted to Phe resulted in the reduction in BCR-mediated Rac1 activation, when compared with the case of wild-type. Altogether, these data suggest that 3BP2 is involved in the activation of Rac1 through the regulation of Vav3 by Syk-dependent phosphorylation of Tyr(426) following BCR stimulation.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  3BP2; Abl; Adaptor proteins; B cell receptor; Syk; Vav3

Mesh:

Substances:

Year:  2014        PMID: 24406398     DOI: 10.1016/j.yexcr.2013.12.026

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  7 in total

1.  Dectin-1-mediated signaling leads to characteristic gene expressions and cytokine secretion via spleen tyrosine kinase (Syk) in rat mast cells.

Authors:  Yukihiro Kimura; Kazuyasu Chihara; Chisato Honjoh; Kenji Takeuchi; Shota Yamauchi; Hatsumi Yoshiki; Shigeharu Fujieda; Kiyonao Sada
Journal:  J Biol Chem       Date:  2014-09-22       Impact factor: 5.157

2.  SH3BP2 cherubism mutation potentiates TNF-α-induced osteoclastogenesis via NFATc1 and TNF-α-mediated inflammatory bone loss.

Authors:  Tomoyuki Mukai; Shu Ishida; Remi Ishikawa; Teruhito Yoshitaka; Mizuho Kittaka; Richard Gallant; Yi-Ling Lin; Robert Rottapel; Marco Brotto; Ernst J Reichenberger; Yasuyoshi Ueki
Journal:  J Bone Miner Res       Date:  2014-12       Impact factor: 6.741

3.  SH3BP2 gain-of-function mutation exacerbates inflammation and bone loss in a murine collagen-induced arthritis model.

Authors:  Tomoyuki Mukai; Richard Gallant; Shu Ishida; Teruhito Yoshitaka; Mizuho Kittaka; Keiichiro Nishida; David A Fox; Yoshitaka Morita; Yasuyoshi Ueki
Journal:  PLoS One       Date:  2014-08-21       Impact factor: 3.240

4.  Association of C-Type Lectin Mincle with FcεRIβγ Subunits Leads to Functional Activation of RBL-2H3 Cells through Syk.

Authors:  Chisato Honjoh; Kazuyasu Chihara; Hatsumi Yoshiki; Shota Yamauchi; Kenji Takeuchi; Yuji Kato; Yukio Hida; Tamotsu Ishizuka; Kiyonao Sada
Journal:  Sci Rep       Date:  2017-04-10       Impact factor: 4.379

5.  Syk-dependent tyrosine phosphorylation of 3BP2 is required for optimal FcRγ-mediated phagocytosis and chemokine expression in U937 cells.

Authors:  Kazuyasu Chihara; Yuji Kato; Hatsumi Yoshiki; Kenji Takeuchi; Shigeharu Fujieda; Kiyonao Sada
Journal:  Sci Rep       Date:  2017-09-13       Impact factor: 4.379

6.  Sh3bp2 Gain-Of-Function Mutation Ameliorates Lupus Phenotypes in B6.MRL-Faslpr Mice.

Authors:  Akiko Nagasu; Tomoyuki Mukai; Masanori Iseki; Kyoko Kawahara; Shoko Tsuji; Hajime Nagasu; Yasuyoshi Ueki; Katsuhiko Ishihara; Naoki Kashihara; Yoshitaka Morita
Journal:  Cells       Date:  2019-04-30       Impact factor: 6.600

Review 7.  Integrin-associated molecules and signalling cross talking in osteoclast cytoskeleton regulation.

Authors:  Lingbo Kong; Biao Wang; Xiaobin Yang; Baorong He; Dingjun Hao; Liang Yan
Journal:  J Cell Mol Med       Date:  2020-02-11       Impact factor: 5.310

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.